Bausch + Lomb Corporation (BLCO)
TSX
Closed
Aug 24, 2026
Day's Range
23.9252 wk Range
19.36Overview - BLCO - Bausch + Lomb Corporation
Key Statistics
Valuation
Enterprise Value
18.39B
P/E (Trailing)
‪-23.51‬
P/E (Forward)
‪15.86‬
PEG Ratio
‪0.30‬
Price / Sales (TTM)
‪1.60‬
Price / Book
‪0.95‬
EV / EBITDA
‪16.37‬
Profitability
Gross Margin
‪62.19%‬
Profit Margin
‪-3.21%‬
Operating Margin
‪7.74%‬
Return on Assets
‪1.82%‬
Return on Equity
‪-2.51%‬
Ownership
Shares Outstanding
357.05M
Float
45.50M
Short % of Shares Outstanding
‪0.13%‬
Held by Insiders
‪87.34%‬
Held by Institutions
‪11.14%‬
Price stats
Beta
‪0.55‬
50-Day Avg
‪22.89‬
200-Day Avg
‪22.76‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
12 analysts
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BLCO - Bausch + Lomb Corporation
Peers - BLCO - Bausch + Lomb Corporation
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on TSX.
- BLCOTSXBausch + Lomb Corporation8.54BMarket Cap+15.59%52-week change-23.45P/E (Trailing)‪-3.21%‬Profit Margin
- ISRGTSXIntuitive Surgical, Inc. ADR184.29BMarket Cap-28.44%52-week change41.00P/E (Trailing)‪65.99%‬Profit Margin
- MRCTSXMorguard Corporation1.22BMarket Cap-2.17%52-week change5.97P/E (Trailing)‪18.46%‬Profit Margin
- ALCTSXAlgoma Central Corporation987.42MMarket Cap+29.62%52-week change5.89P/E (Trailing)‪20.67%‬Profit Margin
- FIETSXiShares Canadian Financial Monthly Income Fund982.12MMarket Cap+17.32%52-week change17.69P/E (Trailing)—Profit Margin
- PRMTSXBig Pharma Split Corp.19.57MMarket Cap+20.72%52-week change12.00P/E (Trailing)—Profit Margin
Profile Summary - BLCO - Bausch + Lomb Corporation
About
Bausch + Lomb Corporation, a leading health care company, primarily focuses on eye health products. The corporation specializes in the development, manufacture, and marketing of a comprehensive range of contact lenses, lens care products, ophthalmic pharmaceuticals, and surgical devices, all designed to improve sight…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
